SAM-e(S-adenosyl-L-methionine) has gained worldwide recognition for its efficacy. As the SAM-e market becomes more mature and booming, the company has optimized the technology and saved cost, looking to expand production capability to 30t in the next two years.
Our SAMe-wayTM SAM-e has a high purity of 98%min, with a high ratio of s,s isomer which is the active substance. The main problem associated with the use of S-adenosyl-L-methionine is its structural instability. Salt forms of SAM-e are more stable for use as a supplement. Our SAM-e is available in two salt forms: Ademetionine 1,4-Butanedisulfonate and Ademetionine Disulfate Tosylate. The main final form that is sold in the market as a supplement is enteric-coated tablet containing SAM-e salt.
Now the company is making both SAM-e raw material as well as tablets for the US market.
As a contract manufacturer of dietary supplements, we have recently developed new SAM-e tablets using our SAM-e raw material. The SAM-e tablets are enterically coated in order to prevent breakdown by stomach acidity and promote intact absorption in the small intestine. Compression is the critical processing for SAM-e tablet manufacturing. We have carried out intense investigation on a variety of systems in order to improve the stability of SAM-e tablets. Stability studies are conducted on the SAMe tablets. On finished tablets, the result so far show reason for optimism. We intend to apply for a patent for this new tablet production technology.
Fenchem is specialized in developing, manufacturing and marketing active ingredients for dietary supplement and functional foods, and has officially stepped into contract manufacturing of dietary supplements recently. The products are manufactured adherence to premium quality that is guaranteed by practices of GMP, HACCP and ISO certification.